Evolution of high-dose cisplatin

High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis

1977 • 622 citations

Intraperitoneal Cisplatin with Systemic Thiosulfate Protection

1982 • 494 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model

1977 • 260 citations

Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.

1979 • 240 citations

High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

1985 • 225 citations

Kinetics of cis‐dichlorodiammineplatinum

1979 • 192 citations

Alterations in the toxicity of cis-Dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration

1981 • 170 citations

High-dose cisplatin with sodium thiosulfate protection.

1985 • 148 citations

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

1983 • 146 citations

Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.

1980 • 146 citations

Clinical trials of cis-diamminedichloroplatinum (NSC-119875).

1973 • 133 citations

cis-Dichlorodiammineplatinum(II). Acid Hydrolysis and Isotopic Exchange of the Chloride Ligands¹

1961 • 127 citations

Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats.

1979 • 104 citations

Cis-diamminedichloroplatinum (II) by 5-day continuous infusion a new dose schedule with minimal toxicity

1984 • 98 citations

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.

1985 • 79 citations

Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

1977 • 77 citations

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate

1984 • 75 citations

Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets.

1985 • 74 citations

Clinical pharmacology of high-dose cisplatin

1985 • 65 citations

Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat.

1983 • 65 citations

High-dose cisplatin in advanced head and neck cancer

1987 • 63 citations

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer.

1986 • 62 citations

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.

1987 • 61 citations

Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide.

1977 • 47 citations

High-dose cisplatin in patients with advanced malignancies

1985 • 46 citations

High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors

1986 • 40 citations

Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms.

1985 • 24 citations

Disseminated testicular cancer with bulky disease: results of a phase‐II study with cisplatin ultra high dose/VP‐16/bleomycin

1987 • 22 citations

Reduced Antineoplastic Activity in Mice of Cisplatin Administered With High Salt Concentration in the Vehicle<xref ref-type="fn" rid="FN2">2</xref>

1984 • 19 citations

High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity

1986 • 12 citations

Cumulative increase in serum cis-platinum levels seen in phase I study of high-dose platinol® (HDP)

1985 • 2 citations